Clinical Trial Update: Safety and Efficacy of Campath in Nonmyeloablative Transplantation [NA]

View source ↗

Summary

A clinical trial update reports on the safety and efficacy of Campath (alemtuzumab) in nonmyeloablative transplantation for lymphoma and leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• CAMPATH (ALEMTUZUMAB)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma, Leukemia | NA | Status: COMPLETED